Loiudice T A, Lang J A
Am J Gastroenterol. 1983 Aug;78(8):481-7.
Twenty-four patients with severe radiation injury to the small bowel seen over a 4-year period were randomized to four treatment groups: 1) methylprednisolone 80 mg intravenously plus Vivonex-HN, 2 L/day po, 2) methylprednisolone 80 mg intravenously plus total parenteral nutrition, 2.5 L/day, 3) total parenteral nutrition, 2.5 L/day, and 4) Vivonex-HN, 2 L/day po. Patients received nothing by mouth except water in groups II and III, and only Vivonex-HN in groups I and IV. Patients were treated for 8-wk periods. Improvement was gauged by overall nutritional assessment measurements, nitrogen balance data and by radiological and clinical parameters. No significant difference between groups I, II, III, and IV could be found for age, sex, mean radiation dosage, time of onset after radiation therapy, or initial nutritional assessment data. Differences statistically could be found between groups II and III and I and IV regarding nutritional assessment data, nitrogen balance, radiographic and clinical parameters after therapy, with marked improvement noted in groups II and III. We conclude that a treatment regimen consisting of total parenteral nutrition and bowel rest is beneficial in the treatment of radiation enteritis. Methylprednisolone appears to enhance this effect and indeed, may be responsible for a longer lasting response.
在4年期间内观察到的24例严重小肠放射性损伤患者被随机分为4个治疗组:1)静脉注射甲泼尼龙80毫克加口服Vivonex-HN,每天2升;2)静脉注射甲泼尼龙80毫克加全胃肠外营养,每天2.5升;3)全胃肠外营养,每天2.5升;4)口服Vivonex-HN,每天2升。第2组和第3组患者除水外禁食,第1组和第4组仅给予Vivonex-HN。患者接受为期8周的治疗。通过全面的营养评估测量、氮平衡数据以及放射学和临床参数来评估改善情况。第1、2、3和4组在年龄、性别、平均辐射剂量、放疗后发病时间或初始营养评估数据方面未发现显著差异。在营养评估数据、氮平衡、治疗后的放射学和临床参数方面,第2组和第3组与第1组和第4组之间存在统计学差异,第2组和第3组有明显改善。我们得出结论,由全胃肠外营养和肠道休息组成的治疗方案对放射性肠炎的治疗有益。甲泼尼龙似乎可增强这种效果,实际上,可能是导致更持久反应的原因。